Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Journal of Translational Medicine
|
March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma
Francesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Nature Communications
|
May 11, 2023
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response
Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella, et al.
The Journal of Experimental Medicine
|
June 29, 2023
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses
Andrew Chancellor, Robert Alan Simmons, Rahul C Khanolkar, et al.
Science Translational Medicine
|
June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
Cristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Journal of Translational Medicine
|
March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma
Francesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Nature Communications
|
May 11, 2023
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response
Vincenzo Salemme, Mauro Vedelago, Alessandro Sarcinella, et al.
The Journal of Experimental Medicine
|
June 29, 2023
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses
Andrew Chancellor, Robert Alan Simmons, Rahul C Khanolkar, et al.
Science Translational Medicine
|
June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
Cristina Mastini, Marco Campisi, Enrico Patrucco, et al.
Page
of 6